"10.1371_journal.pone.0050717","plos one","2012-12-20T00:00:00Z","Taneli Heikkinen; Kimmo Lehtimäki; Nina Vartiainen; Jukka Puoliväli; Susan J Hendricks; Jack R Glaser; Amyaouch Bradaia; Kristian Wadel; Chrystelle Touller; Outi Kontkanen; Juha M Yrjänheikki; Bruno Buisson; David Howland; Vahri Beaumont; Ignacio Munoz-Sanjuan; Larry C Park","Charles River Discovery Research Services, Kuopio, Finland; MBF Labs, Williston, Vermont, United States of America; Neuroservice SARL, Aix-en-Provence, France; CHDI Management/CHDI Foundation, Los Angeles, California, United States of America","Conceived and designed the experiments: LP DH VB IMS TH. Performed the experiments: TH KL NV SJH AB KW CT. Analyzed the data: JP BB JMY. Contributed reagents/materials/analysis tools: OK JRG. Wrote the paper: TH KL SJH AB VB LP.","CHDI Foundation is a not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntingtons disease. CHDI Foundation conducts research in a number of different ways; for the purposes of this manuscript, all research was conceptualized, planned, and directed by CHDI, Charles River Discovery Research Services, Neuroservice SARL and MBF Labs scientific staff and conducted at the contract research organizations Charles River Research Discovery Services, Neuroservice SARL and MBF Labs.","2012","12","Taneli Heikkinen","TH",16,TRUE,5,7,3,6,TRUE,FALSE,FALSE,0,NA,FALSE
